Study at a glance
How were vitamin D signals, the gut lining and gut microbes studied?
Cell and animal experiments examined vitamin D receptor signals, the intestinal lining and gut microbes. Two small human trials tested vitamin D supplements. Removing a receptor, giving active hormone or using a drug that activates the receptor is different from giving a nutritional supplement to a person.
How did vitamin D signals affect the gut lining in animals?
Low vitamin D or receptor loss worsened intestinal injury caused by chemicals in mice, including leakage of a test substance through the lining. Other experiments supported protective responses involving selected chains of signals inside cells. In injured rats, active vitamin D partly improved measurements of cell replacement and the gut barrier. Removing the receptor also changed selected microbes and their products, with results depending on tissue, diet and sex.
Did supplements improve the gut lining or microbes in people?
A three-month trial in 27 people with Crohn’s disease in remission found no clear difference between vitamin D and placebo in permeability (how easily substances passed through the intestinal lining), inflammatory or defence markers, disease activity or quality of life. A separate trial analysing 41 mostly young, healthy adults found some microbial changes. It did not demonstrate improved barrier function or less inflammation throughout the body.
Do these studies show one proven route to better gut health?
The animal studies did not establish every proposed mechanism or measure the entire process of replacing intestinal cells. In the healthy-adult trial, differences in gut microbes at the start, other gummy ingredients and conflicting descriptions of when treatment was given limited interpretation. Regrouping Crohn’s participants by their final vitamin D levels did not establish a treatment target. These studies do not show one proven chain from supplements to healthier microbes, a better barrier and reduced inflammation.
Read the full article below ↓Intestinal vitamin D receptor experiments connect signalling with measured permeability, epithelial renewal and microbial metabolism. Human supplementation trials test separate parts of that relationship. For the full methods and comparison, see Intestinal VDR, Barrier Function and Microbial Metabolism: Full Evidence Review.
Experimental barrier and renewal findings
Li and colleagues found that vitamin D deficiency or whole-body VDR loss worsened chemical colitis in mice, including fluorescent-tracer leakage and junction-protein disruption. Receptor activation and Notch inhibition in epithelial models supported a partly Notch-dependent response. Promoter reporters and predicted binding sequences did not directly establish native VDR binding to the Notch-1 promoter. The work used experimental injury and an active receptor agonist, not a human nutritional treatment.
Wang’s separate rat study measured proliferation, apoptosis-related staining, labelled-cell distribution and permeability during chemically induced liver injury. Calcitriol partly improved these outcomes. The findings address renewal and barrier function, but do not establish a complete replacement rate or prove the proposed HO-1 mechanism. These distinctions matter for Vitamin D and Barrier Immunity.
Microbial profiles and immune context
Chatterjee’s conditional receptor-deletion experiments showed tissue-, diet: and sex-dependent changes in faecal metabolites and selected microbes. The study does not establish that a changed microbial product caused systemic inflammation or that supplementation produces a healthier human microbiome. Exploratory statistical thresholds and conflicting directions for selected metabolites further limit specific mechanistic claims. Vitamin D and Mucosal Defence and Vitamin D and Immune Modulation provide the relevant context.
Human comparisons remain limited
Raftery’s placebo-controlled trial of twenty-seven people with Crohn’s disease in remission found no significant between-group difference in permeability, LL-37, CRP, faecal calprotectin, disease activity or quality of life after three months. More favourable results when participants were regrouped by achieved vitamin D status no longer preserved randomisation and did not establish a blood-level target.
Wyatt’s placebo-controlled trial analysed forty-one mostly young, healthy adults and reported community and taxon changes. Baseline differences, different gummy ingredients and conflicting supplementation timelines limit interpretation. It did not demonstrate improved permeability or reduced systemic inflammation. A microbial change is not itself a validated clinical benefit.
Conclusion
The studies support specific experimental links among receptor signalling, barrier organisation and microbial metabolism. They do not establish supplementation-driven improvement in a human microbiome, barrier function and systemic inflammation as one causal chain. Vitamin D and Inflammatory Signalling helps distinguish those different endpoints.
Sources and publication details
Vitamin D/vitamin D receptor protects intestinal barrier against colitis by positively regulating Notch pathway. Li Y and colleagues. Frontiers in Pharmacology. 2024;15:1421577. DOI: 10.3389/fphar.2024.1421577. PMID: 39130644.
Vitamin D receptor promotes healthy microbial metabolites and microbiome. Chatterjee I and colleagues. Scientific Reports. 2020;10:7340. DOI: 10.1038/s41598-020-64226-7. PMID: 32355205.
Vitamin D Improves Intestinal Barrier Function in Cirrhosis Rats by Upregulating Heme Oxygenase-1 Expression. Wang P and colleagues. Biomolecules & Therapeutics. 2019;27(2):222 to 230. DOI: 10.4062/biomolther.2018.052. PMID: 30173501.
Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: Results from a randomised double-blind placebo-controlled study. Raftery T and colleagues. United European Gastroenterology Journal. 2015;3(3):294 to 302. DOI: 10.1177/2050640615572176. PMID: 26137304.
Randomized control trial of moderate dose vitamin D alters microbiota stability and metabolite networks in healthy adults. Wyatt M and colleagues. Microbiology Spectrum. 2024;12(10):e00083-24. DOI: 10.1128/spectrum.00083-24. PMID: 39189761.
Related reading
Human male gamete endocrinology: 1alpha, 25-dihydroxyvitamin D3 (1,25(OH)2D3) regulates different aspects of human sperm biology and metabolism
A wider biological role of 1alpha,25-Dihydroxyvitamin D3 (1,25(OH)2D3), the active metabolite of vitamin D3, in tissues not primarily related to mineral metabolism was suggested.
Original paper ↗Read more →Isochromosome 12p Formation Regulates Vitamin D Metabolism in Testicular Cancer
Isochromosome 12p (iChr12p) is typical in almost all invasive testicular cancers.
Original paper ↗Read more →Randomized control trial of moderate dose vitamin D alters microbiota stability and metabolite networks in healthy adults
We conducted a double-blind, randomized, placebo-controlled trial to identify the acute and long-term microbiota structural and metabolite changes that occur in response to a moderate dose (4,000 IU) of vitamin D3 for 12 weeks in healthy adults.
Original paper ↗Read more →Vitamin D receptor promotes healthy microbial metabolites and microbiome
We investigated metabolites from mice with tissue-specific deletion of VDR in intestinal epithelial cells or myeloid cells.
Original paper ↗Read more →Intestinal VDR, Barrier Function and Microbial Metabolism: Full Evidence Review
Examine vitamin D receptor experiments on intestinal barriers and microbial metabolism, alongside human trials of permeability, immune markers and microbiota.
Read more →Vitamin D receptor expression controls proliferation of naïve CD8+ T cells and development of CD8 mediated gastrointestinal inflammation
Vitamin D receptor (VDR) deficiency contributes to the development of experimental inflammatory bowel disease (IBD) in several different models.
Original paper ↗Read more →Impairment of Bilirubin Clearance and Intestinal Interleukin-6 Expression in Bile Duct-Ligated Vitamin D Receptor Null Mice
We examined the effect of VDR deletion in a mouse model of cholestasis.
Original paper ↗Read more →Adipose tissue inflammation and VDR expression and methylation in colorectal cancer
Lack of vitamin D (VD) has been associated with colorectal cancer (CRC).
Original paper ↗Read more →Differences in Chronic Low-Grade Inflammation and Metabolic Disturbances between VDR Genotypes in an Ethnically Homogenous Postmenopausal Female Population from Poland
The aim of this study was to assess the differentiation by the VDR genotype of the risk factors for so-called chronic low-grade inflammation and metabolic disorders.
Original paper ↗Read more →Vitamin D Genetics Beyond Serum 25(OH)D: VDR rs2228570 (FokI) Polymorphism, Inflammation, and Quality of Life in Orthopedic Patients
This study investigated the rs2228570 (FokI) variant in relation to inflammatory, hematologic, and patient-reported outcomes in orthopedic patients.
Original paper ↗Read more →RNF20 and RNF40 regulate vitamin D receptor-dependent signaling in inflammatory bowel disease
Here, we aimed to examine the function of the RNF20/RNF40/H2Bub1 axis in intestinal inflammation in IBD patients and mouse models.
Original paper ↗Read more →Vitamin D Receptor Polymorphisms Are Associated with 25(OH)D3 Concentrations and Systemic Inflammation in Decompensated Cirrhosis
In this study, we aimed to investigate the impact of Vitamin D receptor (VDR) polymorphisms (SNPs), as surrogates for functional relationships, on 25(OH)D3 status and systemic inflammation in decompensated liver cirrhosis.
Original paper ↗Read more →Vitamin D’s Effect on the Proliferation and Inflammation of Human Intervertebral Disc Cells in Relation to the Functional Vitamin D Receptor Gene FokI Polymorphism
The aim of this study was to investigate the response of disc cells to vitamin D in terms of the regulation of proliferation, metabolism, and inflammatory processes, with a particular focus on the FokI VDR genotype.
Original paper ↗Read more →Vitamin D3 inhibits lipopolysaccharide-induced placental inflammation through reinforcing interaction between vitamin D receptor and nuclear factor kappa B p65 subunit
The present study investigated the effects of maternal VitD3 supplementation during pregnancy on LPS-induced placental inflammation and fetal intrauterine growth restriction (IUGR).
Original paper ↗Read more →Dysregulation of Farnesoid X Receptor on Neutrophil Homeostasis Exacerbates Intestinal Inflammation via the mTORC1‐Glycolysis Signaling Pathway
Neutrophils significantly accumulate within the inflamed intestinal mucosa of patients with inflammatory bowel disease (IBD), where the farnesoid X receptor (FXR) is typically downregulated.
Original paper ↗Read more →Supplementation of Vitamin D3 and Fructooligosaccharides Downregulates Intestinal Defensins and Reduces the Species Abundance of Romboutsia ilealis in C57BL/6J Mice
Here, we aim to examine the effect of VD, alone or in combination with FOSs, on intestinal barrier integrity and the secretion of antimicrobial peptides, as well as the gut microbial community.
Original paper ↗Read more →Glutathione Stimulates Vitamin D Regulatory and Glucose-Metabolism Genes, Lowers Oxidative Stress and Inflammation, and Increases 25-Hydroxy-Vitamin D Levels in Blood: A Novel Approach to Treat 25-Hydroxyvitamin D Deficiency
25-Hydroxyvitamin D [25(OH)VD] deficiency/inadequacy is a major public health issue affecting more than 1 billion people worldwide.
Original paper ↗Read more →25-vitamin D reduces inflammation in uremic environment
The aim of this study was to investigate the role of 25-vitamin D on inflammatory pathways in healthy and uremic environment.
Original paper ↗Read more →Maternal vitamin D deficiency impairs Treg and Breg responses in offspring mice and deteriorates allergic airway inflammation
This study aimed at investigating the effects of maternal VitD-deficiency during pregnancy on Treg and Breg responses in offspring mice with house dust mite (HDM)-induced allergic airway inflammation.
Original paper ↗Read more →Vitamin D constrains inflammation by modulating the expression of key genes on Chr17q12-21.1
Vitamin D possesses immunomodulatory functions and vitamin D deficiency has been associated with the rise in chronic inflammatory diseases, including asthma (Litonjua and Weiss, 2007).
Original paper ↗Read more →Vitamin D Signaling in Inflammation and Cancer: Molecular Mechanisms and Therapeutic Implications
Vitamin D and its active metabolites are important nutrients for human skeletal health.
Original paper ↗Read more →Original sources
Vitamin D/vitamin D receptor protects intestinal barrier against colitis by positively regulating Notch pathway
Published in Li Y and colleagues. Frontiers in Pharmacology (2024).
Publication details
Vitamin D/vitamin D receptor protects intestinal barrier against colitis by positively regulating Notch pathway. Li Y and colleagues. Frontiers in Pharmacology. 2024;15:1421577. DOI: 10.3389/fphar.2024.1421577. PMID: 39130644.
Vitamin D receptor promotes healthy microbial metabolites and microbiome
We investigated metabolites from mice with tissue-specific deletion of VDR in intestinal epithelial cells or myeloid cells.
Publication details
Vitamin D receptor promotes healthy microbial metabolites and microbiome. Chatterjee I and colleagues. Scientific Reports. 2020;10:7340. DOI: 10.1038/s41598-020-64226-7. PMID: 32355205.
Vitamin D Improves Intestinal Barrier Function in Cirrhosis Rats by Upregulating Heme Oxygenase-1 Expression
Published in Wang P and colleagues. Biomolecules & Therapeutics (2019).
Publication details
Vitamin D Improves Intestinal Barrier Function in Cirrhosis Rats by Upregulating Heme Oxygenase-1 Expression. Wang P and colleagues. Biomolecules & Therapeutics. 2019;27(2):222 to 230. DOI: 10.4062/biomolther.2018.052. PMID: 30173501.
Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: Results from a randomised double-blind placebo-controlled study
Published in Raftery T and colleagues. United European Gastroenterology Journal (2015).
Publication details
Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: Results from a randomised double-blind placebo-controlled study. Raftery T and colleagues. United European Gastroenterology Journal. 2015;3(3):294 to 302. DOI: 10.1177/2050640615572176. PMID: 26137304.
Randomized control trial of moderate dose vitamin D alters microbiota stability and metabolite networks in healthy adults
We conducted a double-blind, randomized, placebo-controlled trial to identify the acute and long-term microbiota structural and metabolite changes that occur in response to a moderate dose (4,000 IU) of vitamin D3 for 12 weeks in healthy adults.
Publication details
Randomized control trial of moderate dose vitamin D alters microbiota stability and metabolite networks in healthy adults. Wyatt M and colleagues. Microbiology Spectrum. 2024;12(10):e00083-24. DOI: 10.1128/spectrum.00083-24. PMID: 39189761.